SION
Sionna Therapeutics·NASDAQ
--
--(--)
--
--(--)
SION fundamentals
Sionna Therapeutics (SION) released its earnings on Mar 20, 2025: revenue was 0 (YoY --), met estimates; EPS was -3.38 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-3.38
--
Report date
Mar 20, 2025
EPS
Actual | -3.38 |
Forecast | -1.2767 |
Surprise | -164.75% |
Revenue
Actual | 0 |
Forecast | 0 |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Sionna Therapeutics's revenue and profit?What guidance did Sionna Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Sionna Therapeutics next quarter?What were the key takeaways from Sionna Therapeutics’s earnings call?What is Sionna Therapeutics's gross profit margin?What is Sionna Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Sionna Therapeutics's earnings call?What does Sionna Therapeutics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
